Inhibitory effects of artesunate on angiogenesis

Yaoxue Xuebao

Volumn 39, Issue 1, 2004, Pages 29-33

  Chen, Huan Huan ^a   Zhou, Hui Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Angiogenesis; Artesunate; Tumor growth; VEGF

Indexed keywords

ARTESUNATE; CD31 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; ARTEMISININ DERIVATIVE; SESQUITERPENE;

ANGIOGENESIS; ARTICLE; CANCER TRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; STAINING; TUMOR CELL; XENOGRAFT; ANIMAL; ARTEMISIA; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; FEMALE; ISOLATION AND PURIFICATION; MALE; METABOLISM; OVARY TUMOR; PATHOLOGY; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; ANIMALS; ARTEMISIA; ARTEMISININS; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SESQUITERPENES; TUMOR CELLS, CULTURED; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 3242750702     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Folkman J. Angiogenesis in cancer, rheumatoid and disease [J]. Nat Med, 1995,1(1):27-31.
2. Kim KJ, Li B, Winer J. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo [J]. Nature, 1993,362(6423):841-844.
3. Benakis A, Paris M, Loutan L, et al. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers [J]. Am J Trop Med Hyg, 1997,56(1):17-23.
4. Efferth T, Dunstan H, Sauerbrey A, et al. The anti-malarial artesunate is also active against cancer [J]. Int J Oncol, 2001,18(4):767-773.
5. Moore JC, Lai H, Li JR, et al. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat [J]. Cancer Lett, 1995,98 (1):83-87.
6. Satake S, Kuzuya M, Ramas MA, et al. Angiogenic stimuli are essential for survival of vascular endothelial cells in three-dimensional collagen lattice [J]. Biochem Biophys Res Commun, 1998,244(3):642-646.
7. Weidner N, Sample JP, Folkman J, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma [J]. N Engl J Med, 1991,324(1):1-8.
8. Klagsbrun M, Moses MA. Molecular angiogenesis [J]. Chem Biol, 1999,6(8):217-224.
9. Ferrara N, Houck I, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor [J]. J Mol Med, 1999,77(7):527-543.
10. Shen BO, Lee DR, Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via KDR/Flk-1 receptor and a protein kinasa C signaling pathway [J]. J Boil Chem, 1999,274(46):33057 -33063.
11. Claffey KP, Brow LF, Aguila LF. Expression of vascular permeability factor / vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis [J]. Cancer Res, 1996,56(1):172 -182.